Development of a therapy against metastatic bladder cancer using an interleukin-2 surface-modified MB49 bladder cancer stem cells vaccine
Crossref DOI link: https://doi.org/10.1186/s13287-015-0211-1
Published Online: 2015-11-14
Published Print: 2015-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Zhu, Yong-tong
Pang, Shi-yu
Lei, Cheng-yong
Luo, Yang
Chu, Qing-jun
Tan, Wan-long
Text and Data Mining valid from 2015-11-14
Version of Record valid from 2015-11-14
Article History
Received: 4 August 2015
Revised: 28 September 2015
Accepted: 22 October 2015
First Online: 14 November 2015